Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: Interim results of a comparative efficacy randomized controlled trial

Healing of diabetic foot ulcers is a major challenge. Despite adhering to optimal standard of care (SOC), less than 30% of wounds heal after 20 weeks. Advanced cellular tissue‐based products have shown better healing over SOC, albeit with great cost and modest improvement. We hypothesized no differe...

Ausführliche Beschreibung